CLART HPV is an in vitro diagnostics product line for the detection and genotyping of different types of human Papillomavirus (HPV) by means of multiplex PCR followed by visualization in low-density arrays, based on CLART Technology.
CLART HPV Line allows to detect HPV genotypes of both, High and Low Risk, in a single trial. Classification of HPV types into high or Low Risk is determined by the innate ability of viruses considered high risk to cause cervical cancer and their involvement in other cancer types (pharyngeal, anal …). CLART HPV Line also enables to detect co-infections in a sample, thereby facilitating follow up of patients with a long-term infection. Genotyping of HPV infection provides a tool both to monitor infection in a single patient, and also to carry out epidemiological studies in those populations where vaccination has already been implemented in girls.